DCGI gives nod to Bharat Biotech to conduct phase I and II Human clinical trials to develop vaccine

Credit: Mid-Day- Published 2 days ago
New Delhi: The Drug Controller General of India (DCGI) has granted permission to Bharat Biotech International Limited (BBIL) to conduct Phase I and II Human clinical trials to develop an indigenous vaccine for COVID-19 -- in the name COVAXIN.

For this, Indian Council of Medical Research (ICMR) and BBIL had partnered to develop...

Video credit: Oneindia
Published 2 days ago -  01:17
Covid-19 vaccine: India ready for human trials of indigenously developed Covaxin | Oneindia News
India is now ready for clinical trials of a potential covid 19 vaccine approved by the Drug controller general of India. Covaxin will enter Phase I and II human trilas from July across the country. #covaxin #covid #vaccine

You are here

Related videos from verified sources

Coronavirus Vaccine: How Close Are We? 00:36
Credit: Wochit News - Published 14 hours ago 

Race to create a vaccine 02:29
Credit: KTNV Channel 13 Las Vegas - Published 2 days ago 

China Approves COVID-19 Vaccine For Human Trials In Military Personnel 00:30
Credit: Wochit - Published 2 days ago 

Related news from verified sources

Indiaโ€™s first Covid-19 vaccine candidate Covaxin, developed by Hyderabad-based Bharat Biotech in collaboration with the National Institute of Virology (NIV),...
3 days ago • IndiaTimes